Rectal Indomethacin vs Intravenous Ketorolac

Status Recruiting

Clinical Trial Summary

Endoscopic retrograde cholangiopancreatography (ERCP) is an essential procedure that can be complicated by post-ERCP pancreatitis (PEP). Indomethacin and ketorolac are two medications used to prevent PEP. The main reason for this research study is to compare the effectiveness these drugs at reducing rates of PEP. There have been no studies comparing the effectiveness of these medications in preventing PEP in pediatric patients. You are being asked to take part in this research study because you are scheduled to have an ERCP as part of your medical care.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05664074
Study type	Interventional
Source	Children's Hospital Medical Center, Cincinnati
Contact	Tyler Thompson, BS
Phone	513-517-1055
Email	tyler.thompson@cchmc.org
Status	Recruiting
Phase	Phase 4
Start date	November 7, 2022
Completion date	June 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546867` - Establishing a Sonographic Based Algorithm to Verify Pancreatic Stent Position Placed to Prevent Post-ERCP Pancreatitis Before Endoscopic Removal	N/A
Terminated	`NCT02241512` - IV Ibuprofen for the Prevention of Post-ERCP Pancreatitis	Phase 2
Completed	`NCT00222092` - Somatostatin, Octreotide, Pentoxyfilline in the Prevention of Post-ERCP Pancreatitis and Molecular Markers	Phase 4
Completed	`NCT05310409` - PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms
Not yet recruiting	`NCT06260878` - Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis	Phase 4
Not yet recruiting	`NCT04770857` - Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
Completed	`NCT02641561` - Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis	Phase 3
Active, not recruiting	`NCT04145336` - 7 cm vs. 5 cm Pancreatic Stents for the Prevention of Post-ERCP Pancreatitis in High-risk Patients	N/A
Completed	`NCT03629600` - Trial of Aggressive Hydration Versus Rectal Indomethacin for Prevention of Post-ERCP Pancreatitis	Phase 2/Phase 3
Recruiting	`NCT03756116` - Effect of Papillary Epinephrine Spraying for the Prevention of Post-ERCP Pancreatitis in Patients Received Octreotide	N/A
Completed	`NCT02308891` - A Prospective Trial of Aggressive Hydration Strategy to Reduce Post-ERCP Pancreatitis	N/A
Recruiting	`NCT05336630` - Study of Forceps Cannulation During ERCP	N/A
Recruiting	`NCT05857514` - Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis	N/A
Recruiting	`NCT05267379` - An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis
Recruiting	`NCT05947461` - Prevention of Post-ERCP Pancreatitis by Indomethacin vs Diclofenac	N/A
Completed	`NCT03098082` - Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis	N/A
Recruiting	`NCT02839356` - Epinephrine Sprayed on the Papilla for the Prevention of Post-ERCP Pancreatitis	Phase 4
Recruiting	`NCT02830984` - ENBD After Endoscopic Sphincterotomy Plus Large-balloon Dilation for Preventing PEP	N/A
Completed	`NCT01673763` - Post-ERCP Pancreatitis Prevention by Stent Insertion	N/A
Active, not recruiting	`NCT04425993` - Rectal Indomethacin Versus Rectal Indomethacin and Sublingual Nitrate for PEP Prevention	N/A